Медицинская литература. Новинки

 

 

 

 

 

 

Выбор объема оперативного вмешательства при очаговых заболеваниях печени

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1. Biecker E., Fischer H.P., Strunk H., Sauerbruch T. Benign hepatic tumours // Z. Gastroenterol. 2003. V. 41. P. 191–200.
2. Cobey F.C., Salem R.R. A review of liver masses in pregnancy and
a proposed algorithm for their diagnosis and management // Am.
J. Surg. 2004. V. 187. P. 181–191.
3. Вишневский В.А., Кубышкин В.А., Чжао А.В., Икрамов Р.З.
Операции на печени. М., 2003.
4. Полысалов В.Н., Гранов Д.А. Хирургическое лечение гемангиом печени: зависимость хирургической тактики от формы заболевания // Вопр. онкологии 2003. Т. 49. № 5.
С. 630–635.
5. Hanazaki K., Kajikawa S., Matsushita A. et al. Hepatic Resection
of Giant Cavernous Hemangioma of the Liver // J. Clin.
Gastroenterol. 1999. V. 29. P. 257–260.
6. Щеголев А.И., Тинькова И.О, Мишнев О.Д. Классификация и
морфологическая характеристика опухолей печени: доброкачественные эпителиальные опухоли (лекция) //
Мед. виз. 2006. №1 . С. 29–38.
7. Yoon S.S., Charny C.K., Fong Y. et al. Diagnosis, management,
and outcomes of 115 patients with hepatic hemangioma //
J. Am. Coll. Surg. 2003. V. 197. P. 392–402.
8. Алимпиев С.В. Диагностика и лечение доброкачественных
опухолей печени: Автореф. дисс. … канд. мед. наук. М., 2001.
9. Tsai H.P., Jeng L.V., Lee W.C., Chen M.F. Clinical Experience
of Hepatic Hemangioma Undergoing Hepatic
Resection // Dig. Dis. Scien. 2003. V. 48. P. 916–920.
10. Lerner M., Hiatt R., Salamandra J. et al. Giant Cavernous Liver
Hemangiomas: Effect of Operative Approach on Outcome //
Arch. Surg. 2004. V. 139. P. 818–821.
11. Hazinedaroglu S., Huseyin K., Mehmet Y.A. Enucleation of
Centrally Located Giant Hepatic Hemangioma: Report of Two
Cases. // Dig. Dis. Scien. 2006. V. 51. P. 1213–1217.
12. Zimmermann A., Baer H.U. Fibrous tumorliver interface in large
hepatic neoplasms: its significance for tumor resection and enucleation // Liver. Transpl. Surg. 1996. V. 2. P. 192–199.
13. Brouwers M.A., Peeters P.M., de Jong K.P. et al. Surgical treatment of giant haemangioma of the liver // Br. J. Surg. 1997.
V. 84. P. 314–316.
14. Choi B.Y., Nguyen, M.H. The Diagnosis and Management of
Benign Hepatic Tumors // J. Clin. Gastroenterol. 2005. V. 39.
Р. 401–412.
15. Federle M.P., Brancatelli G. Imaging of benign hepatic masses //
Semin Liver. Dis. 2001. V. 21. P. 237–249.
16. Trotter J.F., Everson G.T. Benign focal lesions of the liver //
Clin. Liver Dis. 2001. V. 5. P. 17–42.
17. Nguyen B.N., Fléjou J.F., Terris B. et al. Focal Nodular
Hyperplasia of the Liver: A Comprehensive Pathologic Study of
305 Lesions and Recognition of New Histologic Forms // Am. J.
Surg. Pathol. 1999. V. 23(12). P. 14–41.
18. Descottes B., Glineur D., Lachachi F. et al. Laparoscopic liver
resection of benign liver tumors // Surg. Endosc. 2003. V. 17.
P. 23–30.
19. Chun Hsee L., McCall J.L., Koea J.B. Focal nodular hyperplasia:
what are the indications for resection? // HPB (Oxford).
2005.V. 7. P. 298–302.
20. Li T., Qin L.X., Ji Y. et al. Atypical hepatic focal nodular hyperplasia presenting as acute abdomen and misdiagnosed as hepatocellular carcinoma // Hepatol. Research. 2007. V. 37.
P. 1100–1105.
21. De Rave S., Hussain S.M. A liver tumour as an incidental finding:
differential diagnosis and treatment // Scand J. Gastroenterol.
2002. V. 236. P. 81–86.
22. Lee P.J. Glycogen storage disease type I: pathophysiology of liver
adenomas // Eur. J. Pediatr. 2002. V. 161 (Suppl. 1). P. 46–49.
23. Barthelmes L., Tait L.S. Liver cell adenoma and liver cell adenomatosis // HPB. 2005. V. 7. P. 186–196.
24. Sandonato L., Cipolla C., Graceffa G. et al. Giant hepatocellular
adenoma as cause of severe abdominal pain: a case report //
J. Med. Case Reports. 2007. V. 1. P. 57.
25. Edmonson H.A., Henderson B., Benton B. Liver cell adenomas
association with use of oral contraceptives // N. Engl. J Med.
1976. V. 294. P. 470–472.
26. Grazioli L., Federle M.P., Brancatelli G. et al. Hepatic adenomas:
imaging and pathologic findings // Radiographics. 2001. V. 21.
P. 877–892.
27. Kim J., Ahmad S.A., Lowy A.M. et al. An algorithm for the accurate identification of benign liver lesions // Am. J. Surg. 2004.
V. 187. P. 274–279.
28. Патютко Ю.И. Хирургическое лечение злокачественных
опухолей печени. М.: Практическая медицина, 2005.
29. Cho Y.B., Lee K.U., Lee H.W. et al. Outcomes of hepatic resection for a single large hepatocellucar carcinoma // World J. Surg.
2007. V. 31. P. 795–801.
30. El4Serag H.B., Davila J.A., Petersen N.J., Mc Glynn K.A. The
continuing increase in the incidence of hepatocellular carcinoma
in the United States: an update // Ann. Intern. Med. 2003.
V. 139. N 10. P. 817–823.
31. Schottenfeld D., Fraumeni J.F. Cancer Epidemiology and
Prevention. 3rd ed. Oxford University Press, 2006.
32. Bosch F.X., Ribes J., Diaz M., Clerries R. Primary liver cancer:
worldwide incidence and trends // Gastroenterol. 2004. V. 127
(Suppl. 1). P. 5–16.
33. Erichsen R., Jepsen P., Jacobsen J. et al. Time trends in incidence
and prognosis of primary liver cancer and liver metastases of
unknown origin in a Danish region, 1985–2004 // Eur. J.
Gastroenterol. Hepatol. 2008. V. 20. P. 104–110.
34. Hasegawa K., Kokudo N., Imamura H. et al. Prognostic Impact of
Anatomic Resection for Hepatocellular Carcinoma // Ann.
Surg. 2005. V. 242. P. 252–259.
35. Belghiti J., Kianmanesh R. Surgical treatment of hepatocellular
carcinoma // HPB. 2005. V. 7. P. 42–49.
36. Kulik L.M. Advancements in hepatocellular carcinoma //
Current Opinion Gastroenterol. 2007. V. 23. P. 268–274.
37. Makuuchi M., Sano K. The surgical approach to HCC: our
progress and results in Japan // Liver Transpl. 2004. V. 10
(Suppl. 1). P. 46–52.
38. Poon R.T., Fan S.T., Lo C.M. et al. Improving survival results
after resection of hepatocellular carcinoma: a prospective study
of 377 patients over 10 years // Ann. Surg. 2001. V. 234. P. 63–70.
39. Llovet J.M., Fuster J., Bruix J. et al. The Barcelona approach:
diagnosis, staging, and treatment of hepatocellular carcinoma //
Liver Transpl. 2004. V. 10 (Suppl. 1). P. 115–120.
40. Shimozawa N., Hanazaki K. Longterm prognosis after hepatic
resection for small hepatocellular carcinoma // J. Am. Coll.
Surg. 2004. V. 198. P. 356–365.
41. Вишневский В.А., Ефанов М.Г., Икрамов Р.З. и др. Отдаленные результаты обширных и сегментарных резекций печени по поводу гепатоцеллюлярного рака // Анн. хирург. гепатол. 2008. Т. 13. № 3. С. 89.
42. Патютко Ю.И., Лазаревич Н.Л., Сагайдак И.В. и др. Отдаленные результаты хирургического лечения гепатоцеллюлярного рака, прогностические факторы // Анн. хирург.
гепатол. 2008. Т. 13. № 3. С. 98.
43. Полуэктов В.Л., Шутов В.Ю., Подольский Е.Н., Кухта А.К.
Хирургическое лечение гепатоцеллюлярного рака // Анн.
хирург. гепатол. 2008. Т. 13. № 3. С. 99–100.
44. Imamura H., Matsuyama Y., Tanaka E. et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy // J. Hepatol. 2003.
V. 38. P. 200–207.
45. Cha C., Fong Y., Jarnagin W.R. et al. Predictors and patterns of
recurrence after resection of hepatocellular carcinoma // J. Am.
Coll. Surg. 2003. V. 197. P. 753–758.
46. Matsumoto K., Yoshimoto J., Sugo H. et al. Relationship between
the histological degrees of hepatitis and the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis C //
Hepatol. Res. 2002. V. 23. P. 196–201.
47. Regimbeau J.M., Kianmanesh R., Farges O. et al. Extent of liver
resection influences the outcome in patients with cirrhosis and
small hepatocellular carcinoma // Surg. 2002. V. 131. P. 311–317.
48. Teh S.H., Christein J., Donohue J. et al. Hepatic resection of
hepatocellular carcinoma in patients with cirrhosis: Model of
EndStage Liver Disease (MELD) score predicts perioperative
mortality // J. Gastrointest. Surg. 2005. V. 9. P. 1207–1215.
49. Alberts R.S., Gores G.J., Kim G.P. et al. Treatment Options for
Hepatobiliary and Pancreatic // Mayo Clin. Proc. 2007. V. 82.
P. 628–637.
50. National Comprehensive Cancer Network (NCCN): Clinical
Practice Guidelines in Oncology. Hepatobiliary cancers. 2008.
V. 2. www.nccn.org.
51. Makuuchi M., Hasegawa H., Yamazaki S. Ultrasonically guided
subsegmentectomy // Surg. Gynecol. Obstet. 1985. V. 161.
P. 346–350.
52. Abdalla E.К. Is anatomic resection superior to nonanatomic
resection for the treatment of patients with hepatocellular carcinoma? // Nat. Clin. Pract. Gastroenterol. Hepatol. 2006. V. 3.
P. 18–19.
53. Minagawa M., Makuuchi M., Takayama T. Kokudo N. Selection
criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma // Ann. Surg. 2003. V. 238. P. 703–710.
54. Capussotti L., Muratore A., Amisano M. et al. Liver resection for
hepatocellular carcinoma on cirrhosis: analysis of mortality,
morbidity and survival a European single center experience //
2005. V. 31. P. 986–993.
55. Portolani N., Coniglio A., Ghidoni S. et al. Early and Late
Recurrence After Liver Resection for Hepatocellular Carcinoma
Prognostic and Therapeutic Implications // Ann. Surg. 2006.
V. 243. P. 229–235.
56. Mazzaferro V., Chun Y.S., Poon R.T. et al. Liver Transplantation
for Hepatocellular Carcinoma // Ann. Surg. Oncol. 2008. V. 15.
P. 1001–1007.
57. Mazzaferro V., Regalia E., Doci R. et al. Liver transplantation for
the treatment of small hepatocellular carcinomas in patients with
cirrhosis // N. Engl. J. Med. 1996. V. 11. P. 693–699.
58. Bruix J., Fuster J., Llovet J.M. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence based
decision // Liver Transpl. 2003. V. 7. P. 700–702.
59. Duffy J.P., Vardanian A., Benjamin E. et al. Liver Transplantation
Criteria For Hepatocellular Carcinoma Should Be Expanded
A 22 Year Experience With 467 Patients at UCLA // Ann. Surg.
2007. V. 246. P. 502–509.
60. Yao F.Y., Ferrell L., Bass N.M. et al. Liver transplantation for
hepatocellular carcinoma: expansion of the tumor size limits
does not adversely impact survival // Hepatology. 2001. V. 33.
P. 1394–1403.
61. Decaens T., Thoraval F., Bresson H. et al. Impact of UCSF criteria according to preand postOLT tumor features: analysis of 479
patients listed for HCC with a short waiting time // Liver
Transpl. 2006. V. 12. P. 1761–1769.
62. Kneteman N.M., Oberholzer J., Al Saghier M. et al. Sirolimusbased immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma // Liver
Transpl. 2004. V. 10. P. 1301–1311.
63. Onaca N., Davis G.L., Goldstein R.M. et al. Expanded criteria
for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic
Tumors in Liver Transplantation // Liver Transpl. 2007. V. 13.
P. 391–399.
64. Marsh J.W., Dvorchik I. Liver organ allocation for hepatocellular
carcinoma: are we sure? // Liver Transpl. 2003. V. 9. P. 693–696.
65. Parfitt J.R., Marotta P., Alghamdi M. et al. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score
on explanted livers to predict recurrence // Liver Transpl. 2007.
V. 13. P. 543–551.
66. Hamady Z.Z., Cameron I.C., Wyatt J. et al. Resection margin in
patients undergoing hepatectomy for colorectal liver metastasis:
a critical appraisal of the 1cm rule // Eur. J. Surg. Oncol. 2006.
V. 32. P. 557–563.
67. Ikai I., Arii S., Kojiro M. et al. Reevaluation of prognostic factors
for survival after liver resection in patients with hepatocellular
carcinoma in a Japanese nationwide survey // Cancer. 2004.
V. 101. P. 796–802.
68. Sala M., Fuster J., Llovet J.M. et al. High pathological risk of
recurrence after surgical resection for hepatocellular carcinoma:
an indication for salvage liver transplantation // Liver Transpl.
2004. V. 10. P. 1294–1300.
69. Song T.J., Ip E.W., Fong Y. et al. Hepatocellular carcinoma: current surgical management // Gastroenterology. 2004. V. 127
(Suppl. 1). P. 248–260.
70. Пикунов М.Ю., Вишневский А.А., Вишневский В.А. Ион4
кин Д.А. Метастазы колоректального рака в легкие и печень – новые возможности хирургического лечения //
Альманах института хир. им. А.В. Вишневского. 2008. Т. 3.
№ 3. С. 29–32.
71. Paschos K.A., Bird N. Current diagnostic and therapeutic
approaches for colorectal cancer liver мetastasis // Hippokratia.
2008. V. 12. N 3. P. 132–138.
72. Цвиркун В.В., Буриев И.М., Глабай В.П. Резолюция XIV
Международного конгресса хирургов-гепатологов стран
СНГ. “Актуальные проблемы хирургической гепатологии”,
19–21 сентября 2007, СанктПетербург // Анн. хирург. гепатол. 2007. Т. 12. № 4. С. 110–112.
73. Wei A.C., Tung Ping Poon R., Fan S.T., Wong J. Risk factors for
perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma // Br. J. Surg. 2003. V. 90.
P. 33–41.
74. Abdalla E.K., Vauthey J.N., Ellis L.M. et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and
combined resection/ablation for colorectal liver metastases //
Ann. Surg. 2004. V. 239. P. 818–825.
75. Pawlik T., Schulick R.D., Choti M.A. Expanding Criteria for
Resectability of Colorectal Liver Metastases // Oncologist. 2008.
V. 13. P. 51–64.
76. Jarnagin W.R., Gonen M., Fong Y. et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consec
utive cases over the past decade // Ann. Surg. 2002. V. 236.
P. 397–406.
77. Vauthey J.N., Pawlik T.M., Abdalla E.K. et al. Is Extended
Hepatectomy for Hepatobiliary Malignancy Justified? //
Ann. Surg. 2004. V. 239. P. 722–732.
78. Ferrero A., Polastri R., Muratore A. et al. Extensive resections for
colorectal liver metastases // J. Hepatobiliary Pancreat. Surg.
2004. V. 11. P. 92–96.
79. Pawlik T.M., Scoggins С.R., Zorzi D. Effect of Surgical Margin
Status on Survival and Site of Recurrence After Hepatic
Resection for Colorectal Metastases // Ann. Surg. 2005. V. 241.
P. 715–724.
80. Tanaka K., Shimada H., Matsumoto C. et al. Impact of the
Degree of Liver Resection on Survival for Patients with Multiple
Liver Metastases from Colorectal Cancer // World J. Surg. 2008.
V. 32. P. 2057–2069.
81. Fong Y., Fortner J., Sun R.L. et al. Clinical score for predicting
recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases // Ann. Surg. 1999. V. 230.
P. 309–318.
82. Zakaria S., Donohue S.H., Que F.G. et al. Hepatic Resection for
Colorectal Metastases Value for Risk Scoring Systems? //
Ann. Surg. 2007. V. 246. P. 183–191.
83. Welsh F.K., Tekkis P.P., O’Rourke T. et al. Quantification of risk
of a positive (R1) resection margin following hepatic resection
for metastatic colorectal cancer: an aid to clinical decisionmaking // Surg. Oncol. 2008. V. 17. P. 3–13.
84. Барсуков Ю.А. , Алиев В.А. , Черкес В.Л. и др. Циторедуктивные операции при метастатическом колоректальном раке //
Вест. РОНЦ им. Н.Н. Блохина РАМН. 2007. Т. 18. № 3.
С. 15–18.
85. de Haas R.J., Wicherts D.A., Flores E. et al. R1 Resection by
Necessity for Colorectal Liver Metastases Is It Still a Contraindication to Surgery? // Ann. Surg. 2008. V. 248. P. 626–637.
86. Zorzi D., Mullen S.T., Abdalla E.K. et al. Comparison Between
Hepatic Wedge Resection and Anatomic Resection for
Colorectal Liver Metastases // J. Gastrointest. Surg. 2006. V. 10.
P. 86–94.
87. Ekberg H., Tranberg K.G., Andersson R. et al. Determinants of
survival in liver resection for colorectal secondaries // Br. J. Surg.
1986. V. 73. P. 727–731.
88. Cady B., Jenkins R.L., Steele G.D. Jr. et al. Surgical margin in
hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome // Ann. Surg. 1998. V. 227.
P. 566–571.
89. Shirabe K., Takenaka K., Gion T. et al. Analysis of prognostic risk
factors in hepatic resection for metastatic colorectal carcinoma
with special reference to the surgical margin // Br. J. Surg. 1997.
V. 84. P. 1077–1080.
90. Hofmann A., Scheele J. A critical review of the major indicators
of prognosis after resection of hepatic metastases from colorectal
carcinoma // Surg. Oncol. Clin. N. Am. 2003. V. 12. P. 165–192.
91. Jonas S., Thelen A., Benckert C. et al. Extended resection of liver
metastases from colorectal cancer // World. J. Surg. 2007. V. 31.
P. 511–521.
92. Pawlik T.M., Vauthey J.M. et al. Surgical Margins during Hepatic
Surgery for Colorectal Liver Metastases: Complete Resection
not Millimeters Defines Outcome // Ann. Surg. Oncol. 2008.
V. 15. P. 677–679.
93. Konopke R., Kersting S., Makowiec F. et al. Resection of Colorectal
Liver Metastases: Is a Resection Margin of 3 mm Enough?
A Multicenter Analysis of the GAST Study Group // World J.
Surg. 2008. V. 32. P. 2047–2056.
94. Are C., Gonen M., Zazzali K. et al. The Impact of Margins on
Outcome After Hepatic Resection for Colorectal Metastasis //
Ann. Surg. 2007. V. 246. P. 295–300.
95. Патютко Ю.И., Котельников А.Г., Лазарев А.Ф. и др. Резекции печени с предоперационной химио- и биотерапией по
поводу метастазов колоректального рака в печени //
Анн. хирург. гепатол. 2008. Т. 13. № 3. С. 6768.
96. Вишневский В.А., Ефанов М.Г., Икрамов Р.З. и др. Выбор метода хирургического лечения при метастазах колоректального рака в печень. // Анн. хирург. гепатол. 2007. Т. 12. № 3.
С. 131.
97. Shimada H., Tanaka K., Matsuo K., Togo S. Treatment for multiple bilobar liver metastases of colorectal cancer // Langenbecks
Arch. Surg. 2006. V. 391. P. 130–142.
98. Hemming A.W., Reed A.I., Howard R.J. et al. Preoperative portal
vein embolization for extended hepatectomy // Ann. Surg. 2003.
V. 237. P. 686–691.
99. Manfredi S., Lepage C., Hatem C. et al. Epidemiology and
Management of Liver Metastases From Colorectal Cancer //
Ann. Surg. 2006. V. 244. P. 254–259.
100. Adam R., Delvart V., Pascal G. et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict longterm survival // Ann. Surg. 2004.
V. 240. P. 644–657.
101. Covey A.M., Brown K.T., Jarnagin W.R. et al. Combined Portal
Vein Embolization and Neoadjuvant Chemotherapy As
a Treatment Strategy for Resectable Hepatic Colorectal Metastases
// Ann. Surg. 2008. V. 247. P. 451–455.
102. Nuzzo G., Giuliante F., Ardito F. et al. Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy // 2007. V. 11. P. 318–324.
103. Curley S.A., Izzo F., Ellis L.M. et al. Radiofrequency ablation of
hepatocellular cancer in 110 patients with cirrhosis // Ann. Surg.
2000. V. 232. P. 381–391.
104. Pawlik T.M., Izzo F., Cohen D.S. et al. Combined resection and
radiofrequency ablation for advanced hepatic malignancies:
results in 172 patients // Ann. Surg. Oncol. 2003. V. 10.
P. 1059–1069.

Choice of Surgical Extent in the Local Liver Lesions

Keywords: